Supriya Lifescience Limited — Board Meeting, 24-01-2025: Outcome of Board Meeting

The Board of Directors has announced a board meeting, during which they approved the unaudited financial results for the quarter and nine months ending December 31, 2024. Highlights include a revenue from operations of ₹1,856.48 Cr and a profit before tax of ₹625.80 Cr. Additionally, Dr. Ganapati Dadasaheb Yadav and Dr. Sunil Subhash Bhagwat were appointed as Additional Directors (Non-Executive Independent) of the company, pending shareholder approval, each for a term of five years.